# The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps

> **NCT02097394** · PHASE4 · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 200 (actual)

## Conditions studied

- Combizym
- Bifidobacteri
- Colon Polyps

## Interventions

- **DRUG:** Combizym
- **DRUG:** Bifidobacteri
- **DRUG:** Combizym + Bifidobacteri

## Key facts

- **NCT ID:** NCT02097394
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-06
- **Primary completion:** 2020-06
- **Final completion:** 2020-06
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2020-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097394, "The Clinical Study on Combizym and Bifidobacteri to Prevent the Recurrence of Colon Polyps". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02097394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*